installment 发表于 2025-3-23 13:47:29

Epithelial-Mesenchymal Transition (EMT) and Prostate Cancer,yer sheet. During prostate cancer progression, the epithelial cells can undergo epithelial-mesenchymal transition or EMT, characterized by morphological changes in their phenotype from cuboidal to spindle-shaped.This is associated with biochemical changes in which epithelial cell markers such as E-c

collagen 发表于 2025-3-23 13:53:42

http://reply.papertrans.cn/23/2228/222726/222726_12.png

Vulvodynia 发表于 2025-3-23 20:10:24

,A Geneticist’s View of Prostate Cancer: Prostate Cancer Treatment Considerations,ve a desired therapy. In recent years, new strategies have been proposed to treat prostate cancers with poor prognosis by utilizing genetically modified bacteria, including . that preferentially replicate within solid tumors (1000:1 and up to 10,000:1 compared to non-cancerous tissue) destroying can

诱使 发表于 2025-3-23 22:32:15

http://reply.papertrans.cn/23/2228/222726/222726_14.png

mucous-membrane 发表于 2025-3-24 03:41:22

http://reply.papertrans.cn/23/2228/222726/222726_15.png

Robust 发表于 2025-3-24 07:36:03

http://reply.papertrans.cn/23/2228/222726/222726_16.png

Efflorescent 发表于 2025-3-24 13:03:28

Oefenprogramma’s voor schouderaandoeningenng RNAs. Significant research work has shown differential microRNA expression in primary and metastatic prostate cancer suggesting their importance in prostate pathogenesis. We will review the roles of different microRNAs in controlling the various steps in prostate metastasis.

膝盖 发表于 2025-3-24 17:49:07

Oefenprogramma na voorstekruisbandletsel,utilized as drug delivery systems to more effectively target different subpopulations of prostate tumor cells. This chapter reviews progress in using genetically modified . for destruction of prostate tumors.

发表于 2025-3-24 19:16:28

http://reply.papertrans.cn/23/2228/222726/222726_19.png

破布 发表于 2025-3-25 02:13:42

http://reply.papertrans.cn/23/2228/222726/222726_20.png
页: 1 [2] 3 4 5
查看完整版本: Titlebook: Cell & Molecular Biology of Prostate Cancer; Updates, Insights an Heide Schatten Book 2018 Springer International Publishing AG, part of Sp